COVID vaccination now countrywide

Image Credit The Times of India

In the US, vaccines have been distributed based on eligibility in most major cities, and those who still aren't eligible, or are eligible but can't get a vaccination appointment, wonder when it'll be their time to get the vaccine. "One year after the declaration of a pandemic by the World Health Organization, we now see that we are on the right track to accomplish our goals". Read this. Under new protectionist laws they have banned Italy shipping 250,000 AZ jabs to Australia.

"That was what we wanted to find out", said Dr Low, a senior author of the study. If travel is unavoidable, the agency says, vaccinated people should wait two weeks after receiving the second dose of vaccine.

Infectious disease professor Dr. Kim Woo-joo of Korea University, who received a Pfizer vaccine about 10 days ago, said he felt "some pain around the injection spot", which signaled to him that "the vaccine is working". Two masks for vaccinated individuals, however, may be unnecessary, Pelletier said.

They are calling for the government to urgently review its plan to delay the second dose of the vaccine.

Emergency medicine specialist Dr. Paik Jin-hui, who is in his 40s, was inoculated with a Pfizer vaccine on Monday, and said he was "feeling completely fine". "Luckily, I didn't have any of the other more frequently reported symptoms like fever".

Most often, patients complained of a headache after vaccination (22.9%), dizziness (16.8%), and fatigue (16.8%).

Vaccine recipients with preexisting immunity were found to have a higher frequency of mild to moderate side effects like fatigue, headache, chills, muscle pain, fever, and joint pain.

Estonia, Lithuania, Latvia and Luxembourg suspended vaccinations with doses from the same batch, which has been delivered to 17 countries and included one million vaccines.

To date, the Centers for Disease Control and Prevention states on its website, the database "has not detected patterns in cause of death that would indicate a safety problem with COVID-19 vaccines".

In January, the European Commission introduced rules requiring vaccine manufacturers based in European Union countries to get authorisation from the nation where their vaccine is produced before they can export doses.

The vaccine's efficacy in those over 65 has also been questioned in Europe due to a lack of data and before further studies were completed. But that progress pales compared to ten rich countries who possess almost 80 per cent of all COVID-19 vaccines, with some planning to vaccinate their entire population within the next few months. Premier Scott Moe said the province was in the final stretch of the pandemic and the aim was to start vaccinating people aged 60 to 69 by early next month.

The AstraZeneca vaccine is manufactured in multiple countries.

Related:

Comments


Other news